Early Pacemaker Research
In the mid-1950s, Medtronic became acquainted with Dr. C. Walton Lillehei,
a pioneer in open heart surgery at the University of Minnesota Medical
School. At that time, Dr. Lillehei and other surgeons discovered that heart
block occurred after corrective heart surgery in about 10% of their cases.
Silk sutures used in patching the defect interfered with the heart's electrical
impulses, causing abnormally slow rates that were not sufficient to carry
a patient through recovery.
For some time--in fact, since 1803--physicians knew that electricity
was effective in stimulating heart activity. However, pacemakers of the
late 1950s were bulky, relied on external electrodes, and had to be plugged
into a wall outlet. External electric shocks were frequently too traumatic
for young heart block patients, and the AC-operated pacemaker could fail
during a power blackout.
Dr. Lillehei and his colleagues set out to develop a better system,
and Medtronic engineers became closely involved in their work. By 1957,
the research team discovered that by combining a pulse generator with a
wire electrode attached directly to the hearts of dogs, heart rates could
be controlled.
A pacemaker system was then applied successfully to heart block patients,
but physicians still needed to tackle the problems of size and the inconvenient
and unreliable power source. When a power failure knocked out power in
the Twin Cities and resulted in the death of one of Dr. Lillehei's young
patients, the surgeon turned to Earl and Medtronic for a battery back-up
for the AC pacemakers. Over the next few weeks, Earl developed a new kind
of pacemaker that was not much larger than a paperback book. He borrowed
parts from other electrical devices that he had in the shop. For the new
device's circuitry, he relied on a design for a transistorized metronome
he had seen in a trade publication. When finished, he had produced a pacemaker
that was powered by mercury batteries, provided a 9-volt DC pulse, and
could easily and comfortably be worn by young patients.
That original Bakken pacemaker was tested in the University's laboratory;
the following day, it was applied to a pediatric heart block patient. The
effect was instantaneous. The pacemaker immediately restored the child's
heartbeat to near normal. Within days, the child's heart resumed a normal
rhythm on its own and the pacemaker was removed.
The development of the wearable, external, battery-powered pacemaker
amounted to a leap forward in the treatment of heart block and other cardiac
problems. It also signaled the beginning of a new era in the therapeutic
application of electrical technology for patients around the world.
The Hunter-Roth Electrode
The next step in the development of pacing was to improve the electrode
system. Surgeons found that the single wire electrode occasionally dislodged
from the heart or broke; also, the heart's demand for current increased
over time.
The first major improvement in pacing electrodes was developed by Dr.
Samuel Hunter of St. Joseph's Hospital research laboratory in St. Paul,
and Norman Roth, an electrical engineer at Medtronic. They designed a plastic
patch with two imbedded needle-like electrodes. This patch was sutured
to the heart, concentrating the electrical field where it was needed instead
of allowing the current to pass through the body between the internal and
external electrodes. The system required about 70% less current than the
previous pacemaker system. The Hunter-Roth electrode was first implanted
in 1958 in a patient who recovered and lived an additional and active 7
1/2 years.
Expanding Use of External Pacemakers
By 1960, Medtronic had established itself as a manufacturer of biomedical
devices. External pacemakers were in use at the Mayo Clinic in Rochester,
the University of Minnesota in Minneapolis, the National Institutes of
Health in Bethesda, Maryland, Walter Reed Army Medical Center in Washington,
D.C., and Mount Zion Hospital in San Francisco. Medtronic pacemakers had
also been sold in Africa, Australia, Canada, Cuba, Europe, and South America.
In most cases, the external pacemaker was used by patients recovering
from open heart surgery. Several physicians, however, were beginning to
recognize the value of the device in treating patients suffering from chronic
heart block. Yet, long-term application presented several problems: an
external pacemaker worn 24 hours a day was inconvenient for the patient,
the wires could become dislodged from the heart, and most important, the
passage of wires through the skin to the heart introduced the possibility
of infection.
The First Implantable Pacemaker
The first successful attempts at designing a totally implantable pacemaker
were reported by Drs. William Chardack and Andrew Gage at the Veterans
Administration Hospital in Buffalo, New York, and Wilson Greatbatch, an
electrical engineer from upstate New York. Together, they carried out more
than two years of experimental work and testing on dogs before they published
a paper in 1960 entitled: A transistorized, self-contained, implantable
pacemaker for the long-term correction of complete heart block.
A simple addendum to that paper recorded a milestone in the history
of biomedical electronics: the world's first successful long-term implant
in a human patient of a self-contained, internally powered pacemaker. The
pacemaker, potted in epoxy resin, was coated with silicone rubber to protect
it from body fluids, sterilized in a bag of ethylene oxide gas, and slipped
through a skin incision in the left side of the abdomen. It included 10
battery cells and measured 65 mm in diameter and 15 mm thick.
The paper did not go unnoticed by Medtronic, whose founders soon contacted
the New York researchers. On a rainy October evening in 1960, Palmer Hermundslie
flew a private plane to Buffalo, met Dr. Chardack and Greatbatch in the
airport, and signed a contract giving Medtronic exclusive rights to produce
and market the Chardack-Greatbatch implantable pulse generator. Production
of the implantables began in November, and by the end of December, 1960,
Medtronic had received orders for 50 of the $375 units.
Rapid Technological Growth
After development of the implantable pacemaker in 1960, significant
advancements in all areas of pacing occurred rapidly. Highlights of these
are described below.
Transvenous leads. In the mid-1960s, Medtronic introduced its
first transvenous pacing system, which used pacing leads that could be
maneuvered through a vein to the heart without opening the chest or using
general anesthesia. It was believed to be the only such unit manufactured
in the United States at that time.
Tined leads. To overcome dislodgment problems with transvenous
leads, Medtronic developed the first tined leads in the early 1970s. Tines
(soft, pliant projections) at the lead tip allowed the lead to be more
securely entrapped in the supporting structures of the heart, resulting
in a more stable placement. The tined lead (including both ventricular
and atrial J-shaped models) set a new industry standard.
Screw-in myocardial leads. For procedures that required open
heart implants, Medtronic introduced the sutureless, screw-in lead in the
early 1970s. Unlike other myocardial leads that required a stab wound and
sutures for insertion, the sutureless lead had a unique screw-in electrode
that simply rotated into the myocardium (the outside of the heart).
Other advancements in leads. Other important Medtronic developments
in leads included screw-in transvenous leads; smaller lead diameters; smaller,
thinner tines; improved insulation materials and conductor coils; and lead
electrodes designed to reduce the energy needed to pace the heart.
Demand pacing. Another important step in pacing was the development
of a system that avoided competition between the pacemaker's artificial
beats and the patient's own heartbeats. These demand pacemakers were able
to sense when the patient's heart was beating on its own and then provided
pacing only when necessary. Medtronic introduced two demand pacemaker models--an
external and an implantable unit--in 1967. Virtually all pacemakers manufactured
today are demand models.
Power sources. Early pacemakers used mercury-zinc power sources
that yielded expected longevities of 18-24 months. Lithium battery technology
produced a more reliable and durable power source. Medtronic introduced
its lithium-powered Xyrel pacemaker models in 1977. Now, advances in power
sources and energy-efficient pacemakers and leads have extended pacemaker
battery life to more than 10 years in some products.
Circuitry. In the early 1970s, hybrid circuitry contributed to
a significant reduction in the size and weight of pacemakers. In the ensuing
years, research into integrated circuits and microprocessors further reduced
the size of pacemakers while expanding their capabilities. The Thera SR
single chamber, rate responsive pacemaker, for example, is 28.9 mm high
and 7 mm thick (compared to 65 mm high and 15 mm thick for the first implantable
pacemaker developed in 1960).
Dual chamber pacing. Dual chamber pacing is designed to pace
and synchronize both the upper and lower heart chambers. In 1979, Medtronic
introduced its first dual chamber pacemaker, the Byrel. Since then, dual
chamber pacemakers have gained wide acceptance in the medical community,
particularly in the United States where they comprised 59% of all pacemakers
implanted in 1994.
Succeeding generations of dual chamber devices have become significantly
smaller yet have included a greater array of programmable parameters and
other sophisticated features. While the Byrel was 70.5 mm high, 18.2 mm
thick, and weighed 135 grams, the Thera DR dual chamber, rate responsive
pacemaker is 51.3 mm high, 7 mm thick, and weighs 25.5 grams.
Multiprogrammable pacing. Developed in the late 1970s, noninvasive
programmability allowed adjustment of pacemaker parameters to meet a patient's
needs without performing another operation. In 1980, Medtronic introduced
its first multiprogrammable pacemaker--the Spectrax SX device--with nine
adjustable parameters. All modern pacemakers now have noninvasive multiprogrammability.
Rate responsive pacing. In the mid-1980s, Medtronic introduced
its revolutionary rate responsive, activity sensing Activitrax pacing system.
Until rate responsive pacing, single chamber pacemakers functioned at a
fixed rate--generally about 70 beats per minute--regardless of the wearer's
activity and blood-pumping requirements. In the Activitrax pacemaker, a
tiny sensor detected pressure waves caused by a patient's muscle movement
or body motion. The pacemaker's circuitry then translated the pressure
waves into electrical signals that triggered the appropriate rate response
from the pacemaker. Rate responsive pacemakers provided patients with a
level of stamina and endurance not usually possible with fixed-rate pacing
therapy.
Subsequent generations of Medtronic rate responsive, activity sensing
pacemakers have incorporated dual chamber pacing. Others have used different
sensors, including one that detects changes in the frequency and depth
of a patient's breathing.
Serving the Customer
From the early days, customer service was an essential component of
Medtronic's operations. At one time, Earl Bakken, screwdriver in hand,
tended to electrical problems in local operating rooms, and Palmer Hermundslie
piloted his own airplane for emergency deliveries of the company's pacemakers.
This hands-on, person-to-person customer service tradition continues today
with a United States sales team that has doubled in size during the past
10 years and with hundreds of technical support staff members. Supplementing
the face-to-face service are professionals who provide technical assistance
24 hours a day via toll-free telephones.
In international markets, Medtronic sales and technical support teams
serve customers in more than 80 countries. Worldwide operations are grouped
in three organizations: the Americas, Asia/Pacific, and Europe.
Customer Education
An essential element of service at Medtronic is customer education,
which includes product training sessions, the sponsorship of major medical
and scientific seminars and symposia throughout the world, and professionally
accredited workshops.
The first Bakken Education Center, located at Medtronic's Fridley, Minnesota,
headquarters, symbolizes the company's commitment to education. Dedicated
in 1990, the center offers state-of-the-art classrooms, hands-on training
areas, sophisticated audiovisual equipment, and other facilities to serve
physicians, other health care professionals, and Medtronic's sales and
technical support organization.
Additional Bakken Education Centers are located in various cities throughout
the United States and in England, Germany, India, Japan, and The Netherlands.
Thousands of physicians and associated medical professionals take part
in learning sessions at the centers every year, and many others attend
company-sponsored symposia at other locations.
Customer-Focused Quality Programs
Medtronic's emphasis on product quality began in the early days when
a few employees hand-assembled products in a garage. Quality assurance
in those days often meant a close, eyeball inspection by the entire technical
staff. Though the means have changed over the years, the company's insistence
on quality has continued with ongoing efforts in world-class manufacturing
processes, meticulous product testing, and statistical quality controls.
In 1990, Medtronic began its Customer-Focused Quality (CFQ) process,
which incorporated all Medtronic quality strategies, programs, and procedures,
and expanded them throughout all levels of the organization worldwide.
CFQ underscores a total commitment on the part of all Medtronic employees
to focus on customers needs and wants by providing them with unsurpassed
quality in Medtronics products, services, and relationships. Examples of
Medtronic's ongoing quality efforts include:
- having sales representatives available 24 hours a day to ensure that
customers have the appropriate products and support when needed,
- testing Medtronic mechanical heart valves over a span of more than
one billion cycles--67% more than required by the United States Food and
Drug Administrations guidelines,
- publishing a detailed product performance report--unique in the medical
industry--that provides performance data on Medtronic's pacemakers and
leads, and
- conducting customer satisfaction surveys for the collection and assessment
of perceptions and imperatives.